Search Results - "Vlahakos, D V"

Refine Results
  1. 1

    T-cell large granular lymphocyte leukemia presenting as end-stage renal disease: the diagnostic role of flow-cytometric and clonality analysis of the urine sediment by Christopoulos, P D, Katsoudas, S, Androulaki, A, Nakopoulou, L, Economopoulos, T, Vlahakos, D V

    Published in Clinical nephrology (01-02-2009)
    “…A 65-year-old white female patient with normal baseline renal function was referred to our hospital with nonoliguric renal failure requiring hemodialysis after…”
    Get more information
    Journal Article
  2. 2

    Itraconazole-induced rhabdomyolysis and acute renal failure in a heart transplant recipient treated with simvastatin and cyclosporine by VLAHAKOS, D. V, MANGINAS, A, CHILIDOU, D, ZAMANIKA, C, ALIVIZATOS, P. A

    Published in Transplantation (27-06-2002)
    “…Statins are widely used to decrease cholesterol and improve morbidity and mortality associated with coronary artery disease. Myopathy constitutes a rare but…”
    Get full text
    Journal Article
  3. 3

    Colonic perforations after renal transplantation by STELZNER, M, VLAHAKOS, D. V, MILFORD, E. L, TILNEY, N. L

    “…Perforation of the colon is a rare but serious complication in renal transplantation; allograft recipients constitute a patient population uniquely at risk…”
    Get full text
    Journal Article
  4. 4

    Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease by Vlahakos, D V, Kosmas, E N, Dimopoulou, I, Ikonomou, E, Jullien, G, Vassilakos, P, Marathias, K P

    Published in The American journal of medicine (01-02-1999)
    “…An association between activation of the renin-angiotensin system and enhanced erythropoiesis has been observed in patients with several diseases, including…”
    Get more information
    Journal Article
  5. 5

    Relationship between left ventricular hypertrophy and plasma renin activity in chronic hemodialysis patients by VLAHAKOS, D. V, HAHALIS, G, VASSILAKOS, P, MARATHIAS, K. P, GEROULANOS, S

    “…Left ventricular hypertrophy (LVH) is very common in uremic patients. It was shown previously that hemodialysis patients are chronically exposed to the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin II by MATSOUKAS, J. M, POLEVAYA, L, ANCANS, J, MAVROMOUSTAKOS, T, KOLOCOURIS, A, ROUMELIOTI, P, VLAHAKOS, D. V, YAMDAGNI, R, QIAO WU, MOORE, G. J

    Published in Bioorganic & medicinal chemistry (2000)
    “…The novel amide linked Angiotensin II potent cyclic analogue, c-[Sar1,Lys3,Glu5] ANG II 19 has been designed and synthesized in an attempt to test the aromatic…”
    Get full text
    Journal Article
  8. 8

    Transplant renal artery stenosis : hypertension and graft function before and after angioplasty by AGROYANNIS, B, MOURIKIS, D, TZANATOS, H, CHATZIOANNOU, A, VLAHAKOS, D. V, VLACHOS, L

    Published in Journal of human hypertension (01-10-2001)
    “…We present a case, who after 15 years of renal transplantation developed severe deterioration of her hypertension without alteration in renal function. Colour…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Relationship Between Interdialytic Weight Gain and Acid-Base Status in Hemodialysis by Bicarbonate by Agroyannis, B., Fourtounas, C., Tzanatos, H., Dalamangas, A., Vlahakos, D.V.

    Published in Artificial organs (01-04-2002)
    “…: The aim of this study was to determine the relationship between interdialytic weight gain and acid‐base balance pre‐ and posthemodialysis in uremic patients…”
    Get full text
    Journal Article
  11. 11

    Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites by Vlahakos, Demetrios V., Foster, Mary H., Adams, Sharlene, Katz, Michael, Ucci, Angelo A., Barrett, Kathleen J., Datta, Syamal K., Madaio, Michael P.

    Published in Kidney international (01-06-1992)
    “…Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. To investigate the capacity of lupus autoAb to produce glomerular immune…”
    Get full text
    Journal Article
  12. 12

    Anemia due to coadministration of renin-angiotensin-system inhibitors and PPARγ agonists in uncomplicated diabetic patients by Raptis, A E, Bacharaki, D, Mazioti, M, Marathias, K P, Markakis, K P, Raptis, S A, Dimitriadis, G D, Vlahakos, D V

    “…Therapy with either angiotensin converting enzyme inhibitors and angiotensin receptor blockers (ACEI/ARB) or thiazolidinediones (TZD) is associated with…”
    Get more information
    Journal Article
  13. 13

    Renin-angiotensin system stimulates erythropoietin secretion in chronic hemodialysis patients by Vlahakos, D V, Balodimos, C, Papachristopoulos, V, Vassilakos, P, Hinari, E, Vlachojannis, J G

    Published in Clinical nephrology (01-01-1995)
    “…A series of observations suggests an interrelationship between the renin-angiotensin system (RAS) and erythropoietin (EPO) secretion. To further evaluate the…”
    Get more information
    Journal Article
  14. 14

    Enalapril-associated anemia in renal transplant recipients treated for hypertension by Vlahakos, D V, Canzanello, V J, Madaio, M P, Madias, N E

    Published in American journal of kidney diseases (01-02-1991)
    “…We encountered a renal transplant recipient who developed an unexplained 0.09 decrease in hematocrit value while taking enalapril for hypertension, which…”
    Get more information
    Journal Article
  15. 15

    Pre-HD dilution acidosis, without post-HD contraction alkalosis in uremic patients by Agroyannis, B, Fourtounas, C, Tzanatos, H, Kapetanaki, A, Dalamangas, A, Vlahakos, D V

    Published in International journal of artificial organs (01-02-2003)
    “…The aim of this study was to verify if the degree of pre-HD acidosis and its correction post-HD is related to body fluid expansion during the interdialytic…”
    Get full text
    Journal Article
  16. 16

    Hematocrit-lowering effect following inactivation of renin-angiotensin system with angiotensin converting enzyme inhibitors and angiotensin receptor blockers by Marathias, K P, Agroyannis, B, Mavromoustakos, T, Matsoukas, J, Vlahakos, D V

    Published in Current topics in medicinal chemistry (01-01-2004)
    “…Several clinical and experimental observations suggest that an intact and activated renin-angiotensin system (RAS) may be an important determinant of…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20